Literature DB >> 26657833

Invasive aspergillosis before HCT: safe to proceed?

R K Avery1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26657833     DOI： 10.1038/bmt.2015.302

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  9 in total

1.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients.

Authors:  Kieren A Marr; Rachel A Carter; Fulvio Crippa; Anna Wald; Lawrence Corey
Journal:  Clin Infect Dis       Date:  2002-02-26       Impact factor: 9.079

2.  Incidence and outcome of invasive fungal diseases after allogeneic stem cell transplantation: a prospective study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO).

Authors:  Corrado Girmenia; Anna Maria Raiola; Alfonso Piciocchi; Alessandra Algarotti; Marta Stanzani; Laura Cudillo; Clara Pecoraro; Stefano Guidi; Anna Paola Iori; Barbara Montante; Patrizia Chiusolo; Edoardo Lanino; Angelo Michele Carella; Elisa Zucchetti; Benedetto Bruno; Giuseppe Irrera; Francesca Patriarca; Donatella Baronciani; Maurizio Musso; Arcangelo Prete; Antonio Maria Risitano; Domenico Russo; Nicola Mordini; Domenico Pastore; Adriana Vacca; Francesco Onida; Sadia Falcioni; Giovanni Pisapia; Giuseppe Milone; Daniele Vallisa; Attilio Olivieri; Alessandro Bonini; Elio Castagnola; Simona Sica; Ignazio Majolino; Alberto Bosi; Alessandro Busca; William Arcese; Giuseppe Bandini; Andrea Bacigalupo; Alessandro Rambaldi; Anna Locasciulli
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-14       Impact factor: 5.742

3.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.

Authors:  Dimitrios P Kontoyiannis; Kieren A Marr; Benjamin J Park; Barbara D Alexander; Elias J Anaissie; Thomas J Walsh; James Ito; David R Andes; John W Baddley; Janice M Brown; Lisa M Brumble; Alison G Freifeld; Susan Hadley; Loreen A Herwaldt; Carol A Kauffman; Katherine Knapp; G Marshall Lyon; Vicki A Morrison; Genovefa Papanicolaou; Thomas F Patterson; Trish M Perl; Mindy G Schuster; Randall Walker; Kathleen A Wannemuehler; John R Wingard; Tom M Chiller; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

4.  Combination antifungal therapy for invasive aspergillosis: a randomized trial.

Authors:  Kieren A Marr; Haran T Schlamm; Raoul Herbrecht; Scott T Rottinghaus; Eric J Bow; Oliver A Cornely; Werner J Heinz; Shyla Jagannatha; Liang Piu Koh; Dimitrios P Kontoyiannis; Dong-Gun Lee; Marcio Nucci; Peter G Pappas; Monica A Slavin; Flavio Queiroz-Telles; Dominik Selleslag; Thomas J Walsh; John R Wingard; Johan A Maertens
Journal:  Ann Intern Med       Date:  2015-01-20       Impact factor: 25.391

5.  Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Authors:  Catherine Cordonnier; Montserrat Rovira; Johan Maertens; Eduardo Olavarria; Catherine Faucher; Karin Bilger; Arnaud Pigneux; Oliver A Cornely; Andrew J Ullmann; Rodrigo Martino Bofarull; Rafael de la Cámara; Maja Weisser; Effie Liakopoulou; Manuel Abecasis; Claus Peter Heussel; Marc Pineau; Per Ljungman; Hermann Einsele
Journal:  Haematologica       Date:  2010-07-15       Impact factor: 9.941

6.  Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center.

Authors:  Takahiro Fukuda; Michael Boeckh; Katherine A Guthrie; Debra K Mattson; Stephanie Owens; Anna Wald; Brenda M Sandmaier; Lawrence Corey; Rainer F Storb; Kieren A Marr
Journal:  Biol Blood Marrow Transplant       Date:  2004-07       Impact factor: 5.742

7.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

8.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

9.  Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties.

Authors:  O Penack; G Tridello; J Hoek; G Socié; D Blaise; J Passweg; P Chevallier; C Craddock; N Milpied; H Veelken; J Maertens; P Ljungman; J Cornelissen; A Thiebaut-Bertrand; B Lioure; M Michallet; S Iacobelli; A Nagler; M Mohty; S Cesaro
Journal:  Bone Marrow Transplant       Date:  2015-10-26       Impact factor: 5.483
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.